值得买(300785) - 2024 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2024 was ¥296,289,264.84, representing a 16.85% increase compared to ¥253,560,154.41 in the same period last year[4] - The net loss attributable to shareholders was ¥22,711,945.66, a significant increase of 3,202.96% from a loss of ¥687,624.45 in the previous year[4] - Basic and diluted earnings per share were both -¥0.11, reflecting a 1,000% decline from -¥0.01 in Q1 2023[4] - The company reported a net loss of ¥14,289,324.47 for Q1 2024, compared to a net profit of ¥173,229.98 in Q1 2023[22] - The total comprehensive income attributable to the parent company was -22,711,797.29 CNY, compared to -700,417.97 CNY in the previous year, reflecting a worsening financial position[24] Cash Flow and Assets - The net cash flow from operating activities was -¥35,358,705.03, a decrease of 318.52% compared to a positive cash flow of ¥16,181,250.60 in the same period last year[4] - Cash and cash equivalents decreased to ¥691,280,568.38 from ¥728,415,561.00, a decline of 5.1%[20] - The cash and cash equivalents net increase was -¥37,134,992.62, a 62.74% improvement from -¥99,651,923.12 in Q1 2023[8] - The net cash flow from investing activities was -4,279,848.55 CNY, an improvement from -92,935,674.02 CNY in the same quarter last year[27] - The net cash flow from financing activities was 2,536,693.83 CNY, compared to -22,685,488.45 CNY in the previous year, indicating a positive shift[28] Operating Costs and Expenses - The company experienced a 33.36% increase in operating costs, totaling ¥171,030,966.76, compared to ¥128,249,034.83 in the previous year[8] - Total operating costs for Q1 2024 were ¥310,578,589.31, up from ¥255,386,924.43, reflecting a year-over-year increase of 21.6%[22] - The company incurred operating expenses of 421,168,257.15 CNY, which is an increase from 307,572,057.29 CNY in the previous year, reflecting higher operational costs[27] - Research and development expenses increased by 30.33% to ¥42,096,849.21, up from ¥32,299,955.86 in the same period last year[8] - Research and development expenses increased to ¥42,096,849.21, a rise of 30.3% from ¥32,299,955.86 in the previous year[22] Shareholder Information - The total number of common shareholders at the end of the reporting period is 21,766[10] - The largest shareholder, Sui Guodong, holds 36.73% of shares, totaling 73,042,476 shares, with 20,452,900 shares pledged[10] - Liu Feng, the second-largest shareholder, owns 9.11% of shares, amounting to 18,124,323 shares, with 7,505,000 shares pledged[10] - Liu Chao holds 5.41% of shares, which is 10,765,116 shares, with 3,270,000 shares pledged[10] Future Plans and Developments - The company plans to extend the validity period for issuing convertible bonds to November 12, 2024[14] - The company has decided to terminate the issuance of convertible bonds due to changes in capital operation planning and external macroeconomic conditions[15] - The company plans to focus on market expansion and new product development in the upcoming quarters[22] - The company has established the Beijing Worthy Public Welfare Foundation with an investment of RMB 10 million[16] - The company completed the registration of the Beijing Worthy Public Welfare Foundation on February 26, 2024[16] Government Support - The company received government subsidies amounting to ¥2,319,903.05, which are closely related to its normal business operations[5] Miscellaneous - The company has received inquiries from the Shenzhen Stock Exchange regarding the issuance of convertible bonds[13] - The company has not disclosed any changes in the top 10 shareholders' participation in margin trading[11] - Total assets at the end of the reporting period were ¥2,157,402,527.93, down 4.68% from ¥2,263,237,471.89 at the end of the previous year[4] - Total liabilities decreased to ¥315,970,465.14 from ¥400,911,374.15, a reduction of 21.2%[21] - The company’s equity attributable to shareholders decreased to ¥1,832,557,388.43 from ¥1,854,700,953.50, a decline of 1.2%[21] - Accounts receivable decreased to ¥455,716,642.52 from ¥517,404,432.18, a reduction of 11.9%[20] - The company generated 101,313,991.87 CNY in cash inflows from investing activities, significantly higher than 31,487,612.03 CNY in the previous year[27]